| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2134265 | Experimental Hematology | 2011 | 10 Pages |
Abstract
Foamy virus vectors expressing the human gp91phox transgene constitute potential candidates for the gene therapy of CGD because they combine lack of pathogenicity with efficacy even at low MOI.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Ilenia Chatziandreou, Elena Konstantina Siapati, George Vassilopoulos,